143 related articles for article (PubMed ID: 37099516)
1. Cost-effectiveness of screening and valacyclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France.
Périllaud-Dubois C; Hachicha-Maalej N; Lepers C; Letamendia E; Teissier N; Cousien A; Sibiude J; Deuffic-Burban S; Vauloup-Fellous C; Picone O
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):573-584. PubMed ID: 37099516
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
N'Diaye DS; Launay O; Picone O; Tsatsaris V; Azria E; Rozenberg F; Schwarzinger M; Yazdanpanah Y
Vaccine; 2018 Feb; 36(10):1285-1296. PubMed ID: 29397227
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
D'Antonio F; Marinceu D; Prasad S; Khalil A
Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
[TBL] [Abstract][Full Text] [Related]
4. Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis.
Fisher SA; Miller ES; Yee LM; Grobman WA; Premkumar A
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100676. PubMed ID: 35714861
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
Faure-Bardon V; Fourgeaud J; Stirnemann J; Leruez-Ville M; Ville Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
[TBL] [Abstract][Full Text] [Related]
6. Leaning towards Cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective.
Seror V; Leruez-Ville M; Ӧzek A; Ville Y
BJOG; 2022 Jan; 129(2):301-312. PubMed ID: 34651405
[TBL] [Abstract][Full Text] [Related]
7. New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
Egloff C; Sibiude J; Vauloup-Fellous C; Benachi A; Bouthry E; Biquard F; Hawkins-Villarreal A; Houhou-Fidouh N; Mandelbrot L; Vivanti AJ; Picone O
Ultrasound Obstet Gynecol; 2023 Jan; 61(1):59-66. PubMed ID: 35900718
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.
Aoki H; Bitnun A; Kitano T
J Med Virol; 2023 Jan; 95(1):e28391. PubMed ID: 36484373
[TBL] [Abstract][Full Text] [Related]
9. The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis.
Chatzakis C; Shahar-Nissan K; Faure-Bardon V; Picone O; Hadar E; Amir J; Egloff C; Vivanti A; Sotiriadis A; Leruez-Ville M; Ville Y
Am J Obstet Gynecol; 2024 Feb; 230(2):109-117.e2. PubMed ID: 37473793
[TBL] [Abstract][Full Text] [Related]
10. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
[TBL] [Abstract][Full Text] [Related]
11. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
[TBL] [Abstract][Full Text] [Related]
12. Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Deuffic-Burban S; Huneau A; Verleene A; Brouard C; Pillonel J; Le Strat Y; Cossais S; Roudot-Thoraval F; Canva V; Mathurin P; Dhumeaux D; Yazdanpanah Y
J Hepatol; 2018 Oct; 69(4):785-792. PubMed ID: 30227916
[TBL] [Abstract][Full Text] [Related]
13. Universal screening programme for cytomegalovirus infection in the first trimester of pregnancy: study protocol for an observational multicentre study in the area of Barcelona (CITEMB study).
Sanchez-Durán MA; Maiz N; Liutsko L; Bielsa-Pascual J; García-Sierra R; Zientalska AM; Velasco I; Vazquez E; Gracia O; Ribas A; Sitja N; Nadales M; Martinez C; Gonce A; Frick MA; Guerrero-Martínez M; Violán C; Torán P; Falguera-Puig G; Gol R;
BMJ Open; 2023 Jul; 13(7):e071997. PubMed ID: 37474185
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
Albright CM; Werner EF; Hughes BL
Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
[TBL] [Abstract][Full Text] [Related]
15. Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: a case report.
Brosh-Nissimov T; Benshalom-Tirosh N; Bucris E; Morad H; Zuckerman NS; Tepperberg Oikawa M
Int J Infect Dis; 2022 Dec; 125():93-95. PubMed ID: 36229004
[TBL] [Abstract][Full Text] [Related]
16. Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection.
Goncé A; Hawkins-Villarreal A; Salazar L; Guirado L; Marcos MA; Pascual Mancho J; Prats P; López M; Eixarch E; Salvia MD; Fortuny C; Figueras F
J Matern Fetal Neonatal Med; 2022 Oct; 35(20):4004-4008. PubMed ID: 33143511
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden.
Wikström T; Kuusela P; Jacobsson B; Hagberg H; Lindgren P; Svensson M; Wennerholm UB; Valentin L
Ultrasound Obstet Gynecol; 2022 Jun; 59(6):778-792. PubMed ID: 35195310
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China.
Xu Y; Liu Y; Wang J; Che X; Du J; Zhang X; Gu W; Zhang X; Jiang W
Front Public Health; 2022; 10():990042. PubMed ID: 36211670
[TBL] [Abstract][Full Text] [Related]
19. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
[TBL] [Abstract][Full Text] [Related]
20. Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review.
Périllaud-Dubois C; Belhadi D; Laouénan C; Mandelbrot L; Picone O; Vauloup-Fellous C
PLoS One; 2021; 16(12):e0261011. PubMed ID: 34860861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
